These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20573752)

  • 1. Postchallenge glucose, A1C, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease: a 10-year prospective cohort study.
    Cederberg H; Saukkonen T; Laakso M; Jokelainen J; Härkönen P; Timonen M; Keinänen-Kiukaanniemi S; Rajala U
    Diabetes Care; 2010 Sep; 33(9):2077-83. PubMed ID: 20573752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited overlap between intermediate hyperglycemia as defined by A1C 5.7-6.4%, impaired fasting glucose, and impaired glucose tolerance.
    Saukkonen T; Cederberg H; Jokelainen J; Laakso M; Härkönen P; Keinänen-Kiukaanniemi S; Rajala U
    Diabetes Care; 2011 Oct; 34(10):2314-6. PubMed ID: 21816975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.
    Unwin N; Shaw J; Zimmet P; Alberti KG
    Diabet Med; 2002 Sep; 19(9):708-23. PubMed ID: 12207806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycated haemoglobin as a screening test for abnormal glucose homeostasis in childhood obesity.
    Kumbhojkar A; Saraff V; Nightingale P; Högler W
    Diabet Med; 2020 Feb; 37(2):356-361. PubMed ID: 31782826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes: the strong heart study.
    Wang H; Shara NM; Lee ET; Devereux R; Calhoun D; de Simone G; Umans JG; Howard BV
    Diabetes Care; 2011 Sep; 34(9):1952-8. PubMed ID: 21788631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study.
    Cavalot F; Pagliarino A; Valle M; Di Martino L; Bonomo K; Massucco P; Anfossi G; Trovati M
    Diabetes Care; 2011 Oct; 34(10):2237-43. PubMed ID: 21949221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Effects of Fasting Glucose, Hemoglobin A
    Su WY; Chen SC; Huang YT; Huang JC; Wu PY; Hsu WH; Lee MY
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study.
    Kim MK; Jeong JS; Yun JS; Kwon HS; Baek KH; Song KH; Ahn YB; Ko SH
    J Diabetes Complications; 2018 Oct; 32(10):906-910. PubMed ID: 30121206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population.
    Badings EA; Dyal L; Schoterman L; Lok DJ; Stoel I; Gerding MN; Gerstein HC; Tijssen JG
    J Diabetes; 2011 Sep; 3(3):232-7. PubMed ID: 21631894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
    Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
    Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate.
    Hulman A; Vistisen D; Glümer C; Bergman M; Witte DR; Færch K
    Diabetologia; 2018 Jan; 61(1):101-107. PubMed ID: 28983719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).
    Droumaguet C; Balkau B; Simon D; Caces E; Tichet J; Charles MA; Eschwege E;
    Diabetes Care; 2006 Jul; 29(7):1619-25. PubMed ID: 16801588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study.
    Kabootari M; Asgari S; Ghavam SM; Abdi H; Azizi F; Hadaegh F
    J Transl Med; 2021 Jun; 19(1):277. PubMed ID: 34193200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HbA₁(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study.
    Borg R; Kuenen JC; Carstensen B; Zheng H; Nathan DM; Heine RJ; Nerup J; Borch-Johnsen K; Witte DR;
    Diabetologia; 2011 Jan; 54(1):69-72. PubMed ID: 20886203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediabetic increase in hemoglobin A1c compared with impaired fasting glucose in patients receiving antipsychotic drugs.
    Manu P; Correll CU; Wampers M; van Winkel R; Yu W; Mitchell AJ; De Hert M
    Eur Neuropsychopharmacol; 2013 Mar; 23(3):205-11. PubMed ID: 22652493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.
    Mori Y; Hoshino K; Yokota K; Yokose T; Tajima N
    Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):334-9. PubMed ID: 15977101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil.
    Schmidt MI; Bracco PA; Yudkin JS; Bensenor IM; Griep RH; Barreto SM; Castilhos CD; Duncan BB
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):267-277. PubMed ID: 30803929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.